Effectiveness of dasatinib in accelerated-phase chronic myeloid leukemia with p190 BCR-ABL1 and a second Philadelphia chromosome.
Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
Karen E
KE
Rabenau
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
Michelle
M
Dolan
Division of Hematology-Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA.
Sophia
S
Yohe
Division of Hematology-Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA. Electronic address: custun@umn.edu.
Celalettin
C
Ustun
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000069439:Dasatinib; D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D006801:Humans; D015465:Leukemia, Myeloid, Accelerated Phase / Q000188:drug therapy* / Q000235:genetics; D010677:Philadelphia Chromosome; D011743:Pyrimidines / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use*
D000970:Antineoplastic Agents; C581634:BCR-ABL1 fusion protein, human; D011743:Pyrimidines; D013844:Thiazoles; D016044:Fusion Proteins, bcr-abl; D000069439:Dasatinib